The Cutting Edge of Medicine: An Interview With Alejandro Alva, MD
CLINICAL CONVERSATIONS The US Food and Drug Administration (FDA) Advisory Committee Meeting will meet on June 4, 2024, to review investigational MDMA-assisted therapy for posttraumatic stress disorder (PTSD). In our effort to gauge clinician reactions, …